IL1RL1 and Increased total eosinophil count: ILC2 express IL17RB (IL25R) and ST2 (IL33R) and respond to intranasal administration of IL-25 and IL-33 producing IL-13 and IL-5, which contribute to the development of airway hyper-reactivity, eosinophilia, and airway inflammation (55–58).